Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells

1 Feb 2005

Abstract excerpt

Recent data indicate that isomerisation to all-trans retinoic acid (ATRA) is the key mechanism underlying the favourable clinical properties of 13-cis retinoic acid (13cisRA) in the treatment of neuroblastoma. Retinoic acid (RA) metabolism is thought to contribute to resistance, and strategies to modulate this may increase the clinical efficacy of 13cisRA. The aim of this study was to test the hypothesis that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Neuroblastoma Research and Treatments
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15714209
DOI: 10.1038/sj.bjc.6602398

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cellsPMID 15714209Read ↗

Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid.Semantic proximity Read ↗

Metabolic characteristics of 13‐cis‐retinoic acid (isotretinoin) and anti‐tumour activity of the 13‐cis‐retinoic acid metabolite 4‐oxo‐13‐cis‐retinoic acid in neuroblastomaSemantic proximity Read ↗

Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate.Semantic proximity Read ↗

Enhancing Retinoic Acid-mediated Effects Through Inhibition of CYP26A1, CYP26B1 and HGF Signaling in Neuroblastoma CellsSemantic proximity Read ↗

Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic DifferentiationSemantic proximity Read ↗

Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.Semantic proximity Read ↗

CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma CellsSemantic proximity Read ↗

Retinoic-acid-resistant neuroblastoma cell lines show alteredMYC regulation and high sensitivity to fenretinideSemantic proximity Read ↗

Retinoic Acid Confers Resistance to p53-dependent Apoptosis in SH-SY5Y Neuroblastoma Cells by Modulating Nuclear Import of p53Semantic proximity Read ↗

ATRA(ouble) in the treatment of acute promyelocytic leukemia.Semantic proximity Read ↗

All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryosSemantic proximity Read ↗

Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to RetinoidsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.